drugset / Trial / NCT02375867

Steroids in Fulminant Hepatitis A in the Pediatric Age Group

NCT02375867 ↗

RandomizedFactorialOpen-labelTreatment

Summary

Fulminant hepatic failure (FHF) in children is a potentially devastating disease. The mortality rate may reach 80-90% in the absence of liver transplantation. Liver injury is considered to be mainly immune mediated with augmentation of cytolytic pathways of infected hepatocytes. For that, it is suggested that corticosteroids modulate the activity of the disease by suppressing the immune system.

Timeline

Start
2015-01
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 0.8 mg/kg Intravenous
Comparator Prednisolone Other / unclassified 1 mg/kg Oral

Indications